CannMart, a Toronto-based company awaiting licensing from Health Canada to produce medical cannabis, speaks to the current opportunities for medical research at the International Cannabinoid Research Society (ICRS) Symposium, in Italy.
The ICRS symposium gathers academics from around the world to share scientific developments in the field of medical cannabis. Umar Syed, President of CannMart, emphasizes the importance of progressing cannabis research by forming like-minded partnerships and consolidating findings, for the benefit of patients and healthcare professionals alike.
By working with other licensed producers, CannMart aims to contribute to the field by advancing research and education. “While our partnered producers focus on producing the best quality cannabis, we will focus our efforts on research and education to ensure medical practitioners and patients understand the safe and effective use of a wide variety of medical cannabis strains”, said Syed.
Read the full article at Digital Journal
Cannmart advances medical cannabis research
No comments:
Post a Comment